Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer
Neelima Vidula, Andrew Lipman, Shumei Kato, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Liquid biopsy: Cell-free DNA based analysis in breast cancer
Konstantinos Venetis, Giulia Cursano, Carlo Pescia, et al.
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100002-100002
Open Access | Times Cited: 22
Rcoxnet: Deep Learning Framework for Enhanced Cancer Survival Prediction Integrating Random Walk with Restart with Mutation and Clinical Data
Debarka Sengupta, Stuti Kumari, Sakshi Gujral, et al.
(2025)
Closed Access
Protein arginine methyltransferase 6 enhances immune checkpoint blockade efficacy via the STING pathway in MMR-proficient colorectal cancer
Jinlin Duan, Tao Chen, Qiwei Li, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010639-e010639
Open Access
Dynamics of blood microsatellite instability (bMSI) burden predicts outcome of a patient treated with immune checkpoint inhibitors: a case report of hyperprogressive disease
Daria Kravchuk, Alexandra Lebedeva, Olesya Kuznetsova, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Predictors of Immunotherapy Response in Triple Negative Breast Cancer
Yiduo Hu, Rachel Yoder, Priyanka Sharma
Current Breast Cancer Reports (2025) Vol. 17, Iss. 1
Closed Access
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
Keiko Inakami, Noriko Fujita, Chikage Iguchi, et al.
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Assessment of blood-based tumor mutational burden on clinical outcomes in advanced breast and prostate cancer treated with immune checkpoint inhibitors
Pedro C. Barata, Reagan Barnett, Albert Jang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Potential function of microRNA miRNA-206 in breast cancer pathogenesis: Mechanistic aspects and clinical implications
Esmaeel Babaeenezhad, Zohreh Abdolvahabi, Sahar Asgharzadeh, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155454-155454
Closed Access
Hormone Receptor–Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3
Henry G. Kaplan, Jeffrey R. Whiteaker, Brianna Nelson, et al.
Journal of the National Comprehensive Cancer Network (2023) Vol. 21, Iss. 11, pp. 1110-1116
Open Access | Times Cited: 1
Is genomic analysis possible in a tissue acquired via endoscopic ultrasound-guided fine-needle biopsy in cholangiocarcinoma?
Jonghyun Lee, Sung Yong Han
Clinical Endoscopy (2024) Vol. 57, Iss. 3, pp. 332-334
Open Access
Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers
Reagan Barnett, Albert Jang, Sree M Lanka, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access
Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS)
Jean‐Louis Merlin, Marie Husson, Nassim Sahki, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3164-3164
Open Access
Page 1

Scroll to top